company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
"Millendo Therapeutics, Inc.",MLND,,0001544227,2011.0,Q3,2011-01-05,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1440000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2011.0,Q3,2011-01-05,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1440000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2011.0,Q3,2011-01-05,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,306000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2011.0,Q3,2011-01-05,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,84000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2011.0,Q3,2011-01-05,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1050000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2011.0,Q3,2011-01-05,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1050000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2011.0,Q3,2011-01-05,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1050000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 13:19:06+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2966000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 13:19:06+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2966000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 13:19:06+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,259000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 13:19:06+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1889000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 13:19:06+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-818000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 13:19:06+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-818000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 13:19:06+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-431000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 13:19:06+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-431000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 13:19:06+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-431000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 13:19:06+00:00,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,34992000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 13:19:06+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,34992000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 13:19:06+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,34992000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q1,2012-01-01,2012-03-31,2013-05-15 13:19:06+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,33743000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3234000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3234000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,22000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,300000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1006000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3918000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3918000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-25000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-93000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-118000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-118000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-182000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-181000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-181000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4217000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3118000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3118000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,29000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,300000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-147000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2936000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2936000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-248000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-248000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-248000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,182000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4054000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4236000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4236000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1052000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4192000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4192000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,42000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,77000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,523000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,66000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3484000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3484000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-145000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-16698000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-16843000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-16843000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-16000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-16000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-16000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-20343000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 08:07:59+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5157000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 08:07:59+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5157000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 08:07:59+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,47000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 08:07:59+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,108000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 08:07:59+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,837000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 08:07:59+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,109000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 08:07:59+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4056000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 08:07:59+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4056000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 08:07:59+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-184000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 08:07:59+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-184000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 08:07:59+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,32652000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 08:07:59+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,32652000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 08:07:59+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,32652000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 08:07:59+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,28412000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5996000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5996000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,53000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,118000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1374000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-713000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5164000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5164000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-9833000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-9833000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-14995000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12923000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12923000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,114000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,253000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3476000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,545000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8535000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8535000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-312000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,1000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4503000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4192000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4192000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-85000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-85000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-85000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4428000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18890000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18890000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,188000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,233000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7040000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,905000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10524000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10524000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1335000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5990000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4655000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4655000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-21000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,179000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,158000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,158000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5711000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:20:58+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17206000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:20:58+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17206000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:20:58+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,227000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:20:58+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,171000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:20:58+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6838000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:20:58+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4424000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:20:58+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14394000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:20:58+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14394000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:20:58+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-389000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:20:58+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-750000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:20:58+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:20:58+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,19030000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:20:58+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:20:58+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,17891000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:20:58+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,17891000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:20:58+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,124787000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:20:58+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,124787000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:20:58+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,124787000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:20:58+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,128284000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17490000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17490000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,183000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,269000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4740000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,247000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12051000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12051000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-759000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-750000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-68918000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,17816000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-439000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-53050000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-53050000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,641000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,641000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,641000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-64460000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17922000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17922000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,290000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,352000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4015000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,695000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12570000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12522000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1175000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-13154000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7375000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6954000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6954000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,80000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,80000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,80000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-19396000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:27:17+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21758000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:27:17+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21758000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:27:17+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,504000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:27:17+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,295000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:27:17+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3980000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:27:17+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1569000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:27:17+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15410000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:27:17+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15410000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:27:17+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-370000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:27:17+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-750000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:27:17+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-27118000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:27:17+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,20814000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:27:17+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,88000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:27:17+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7336000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:27:17+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7336000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:27:17+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:27:17+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-22746000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18568000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18568000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,596000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,203000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2621000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-738000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15886000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15919000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-498000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-50000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-24000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,37688000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,109000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,37225000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,37275000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,54060000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,54060000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,54060000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,75416000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22643000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22643000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,600000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,52000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3540000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3489000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14962000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14969000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1541000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-17038000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,27005000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,8426000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8426000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-7000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-7000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-7000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6550000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:59:09+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14895000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:59:09+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14895000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:59:09+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,500000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:59:09+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,27000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:59:09+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1819000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:59:09+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2597000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:59:09+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15146000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:59:09+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15185000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:59:09+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-75000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:59:09+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-26562000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:59:09+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,23325000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:59:09+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3312000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:59:09+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3312000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:59:09+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:59:09+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-18497000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18186000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18186000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,500000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,64000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5298000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,244000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12080000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12090000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-26000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-16914000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,26907000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9967000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9967000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2123000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-42139000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-42139000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,-1272000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-101000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,58318000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2444000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,17250000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,17239000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,108000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,550000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,48403000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,462000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,-67839000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-18316000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-18316000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-10465000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,6000000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-4463000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4463000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,19000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5521000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2017.0,Q4,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,213000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 07:23:37+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4386000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 07:23:37+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4386000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 07:23:37+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 07:23:37+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,174000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 07:23:37+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-791000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 07:23:37+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4997000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 07:23:37+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4997000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 07:23:37+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 07:23:37+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-524000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 07:23:37+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-525000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 07:23:37+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-525000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 07:23:37+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-43000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 07:23:37+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-43000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 07:23:37+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-43000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 07:23:37+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,30000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 07:23:37+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5535000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5042000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5042000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,9000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,223000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,109000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4701000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4701000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-523000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-523000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-523000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-34000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5264000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7891000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7891000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1390000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1770000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4723000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4723000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-13000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-13000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-13000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-300000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,8000000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7700000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7700000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-20000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2944000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9858000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9858000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,9000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,675000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-52000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9226000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9226000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-16000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2492000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2476000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2476000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-654000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-808000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,38756000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,33316000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,70610000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,70610000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,24000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,64002000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2018.0,Q4,2018-10-01,2018-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,4000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:36:34+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10366000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:36:34+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10366000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:36:34+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:36:34+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,76000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:36:34+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,939000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:36:34+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1258000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:36:34+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10601000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:36:34+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10601000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:36:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-10000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:36:34+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2986000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:36:34+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2976000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:36:34+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2976000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:36:34+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-60000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:36:34+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:36:34+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:36:34+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:36:34+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-60000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:36:34+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-60000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:36:34+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-14000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 07:36:34+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7699000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9871000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9871000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,11000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-282000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,995000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1426000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10573000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10573000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-267000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1399000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1132000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1132000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-192000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,214000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,22000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,22000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-21000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9440000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11632000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11632000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,33000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-146000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1196000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2192000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8357000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8357000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-87000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-87000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-87000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-127000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,248000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,121000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,121000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,40000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8283000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12699000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12699000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,45000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1307000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1217000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1561000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11691000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11691000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-33000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-33000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-33000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,177000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-15000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,26688000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,10000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,26860000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,26860000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-5000.0
"Millendo Therapeutics, Inc.",MLND,,0001544227,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,15164000.0
